| 发明名称 | Human monocyte sub-population for treatment of central nervous system injury | ||
| 摘要 | A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided. | ||
| 申请公布号 | US9314483(B2) | 申请公布日期 | 2016.04.19 |
| 申请号 | US201414303212 | 申请日期 | 2014.06.12 |
| 申请人 | Yeda Research and Development Co., Ltd. | 发明人 | Eisenbach-Schwartz Michal;Yoles Ester;Shechter Ravid;Miller Omer |
| 分类号 | C12N5/0786;A61K35/15;A61K35/14;A61K35/12 | 主分类号 | C12N5/0786 |
| 代理机构 | Rosenbaum IP, P.C. | 代理人 | Paredes J. Peter;Rosenbaum IP, P.C. |
| 主权项 | 1. A method for treating a CNS injury comprising injecting into the CSF of an individual in need an effective amount of a subpopulation of peripheral blood mononuclear cells (PBMCs) substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and CD16+ cells. | ||
| 地址 | Rehovot IL | ||